41st Annual J.P. Morgan Healthcare Conference

January 2023

Forward-Looking Statements

This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the current beliefs and expectations of NextGen Healthcare management, only speak as of the date that they are made and subject to significant risks and uncertainties. Such statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar terms. Examples of forward-looking statements include, among others, statements we make regarding guidance related to expected operating results, such as revenue growth, net income and earnings per share, strategic growth initiatives, strategy for growth, product development, market position, customer retention, financial results and reserves, anticipated levels of capital expenditures and capital developments.

Actual results could differ materially from those indicated in the forward-looking statements.

Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include, but are not limited to: risks associated with strategic actions, including acquisitions and dispositions, and our ability to successfully integrate acquired businesses and realize the intended benefits; changes in laws, regulations and industry initiatives applicable to our business model; changes in market conditions and receptivity to our services and offerings; increased government involvement in our industry; our or our clients' failure to see the benefits of government programs; changes in interoperability or other regulatory standards; our ability to maintain and expand our business with existing clients or effectively transition clients to newer products; the volume and timing of systems sales and installations; unpredictability of the sales and implementation cycles for our products and services; the possibility that products will not achieve or sustain market acceptance; changes in tax rates or laws; the impact of governmental and regulatory agency investigations, including the Department of Justice matter; our failure to compete successfully; consolidation in our industry; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; changing economic, political or regulatory influences in the health-care industry; our ability to establish and maintain strategic relationships;; the continuing impact of the COVID-19 pandemic; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; business disruptions; security breaches resulting in unauthorized access to our or our clients' computer systems or data, including denial-of-services, ransomware or other Internet-based attacks; caused by acquisitions of companies, products, or technologies; liability for use of content; price reductions; our ability to license and integrate third-party technologies

A significant portion of the Company's quarterly sales of software product licenses is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance.

Additional information about these and other risks, uncertainties, and factors affecting our business is contained in our filings with the Securities and Exchange Commission, including under the caption "Risk Factors" in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Qs. We do not undertake to publicly update forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes in our business, financial condition or operating results over time.

2

David Sides

President and Chief Executive Officer

NextGen Healthcare

is a leading provider of innovative, cloud-based, healthcare technology solutions that empower physician practices to manage the risk and complexity of delivering care in the US healthcare system.

Mission and Value Proposition

Better Healthcare Outcomes for All

Integration

Interoperability

Delivering a broad and highly

Building connected data and

integrated set of solutions and

human networks across

end-user experiences

ambulatory healthcare

Insight

Impact

Providing intelligence at the

Delivering and shaping

point of care to enable better

outcomes in all aspects of our

health and financial decisions

solutions and services

4

Long-Term Goals

  1. Achieve 10% Revenue Growth by FY25
  2. Deliver Operating Leverage in FY24 and Beyond
  3. Deliberate and Disciplined Deployment of Capital

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

NextGen Healthcare Inc. published this content on 11 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 January 2023 08:29:05 UTC.